| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 活血止痛膏(元) | 123,630,141.17 | 262,352,414.82 | 109,282,120.17 | 314,421,104.86 | 155,976,893.54 |
| 基因工程药(元) | 881,828,803.98 | 2,032,058,873.14 | 904,614,923.47 | 1,501,105,871.71 | 706,959,880.49 |
| 其他(元) | - | 571,340,771.99 | - | 515,535,750.72 | - |
| 营业成本(元) | |||||
| 活血止痛膏(元) | 21,109,755.17 | 36,266,248.37 | 19,310,451.84 | 37,570,385.35 | 17,253,963.75 |
| 基因工程药(元) | 121,602,725.63 | 282,943,866.10 | 122,532,367.61 | 189,186,494.05 | 82,055,614.38 |
| 其他(元) | - | 301,134,067.16 | - | 276,618,112.49 | - |
| 毛利(元) | |||||
| 活血止痛膏(元) | 102,520,386.00 | 226,086,166.45 | 89,971,668.33 | 276,850,719.51 | 138,722,929.79 |
| 基因工程药(元) | 760,226,078.35 | 1,749,115,007.04 | 782,082,555.86 | 1,311,919,377.66 | 624,904,266.11 |
| 其他(元) | - | 270,206,704.83 | - | 238,917,638.23 | - |
| 毛利率(%) | |||||
| 活血止痛膏(%) | 82.93 | 86.18 | 82.33 | 88.05 | 88.94 |
| 基因工程药(%) | 86.21 | 86.08 | 86.45 | 87.40 | 88.39 |
| 其他(%) | - | 47.29 | - | 46.34 | - |
| 收入构成(%) | |||||
| 活血止痛膏(%) | 12.30 | 9.15 | 10.78 | 13.49 | 18.08 |
| 基因工程药(%) | 87.70 | 70.91 | 89.22 | 64.40 | 81.92 |
| 其他(%) | - | 19.94 | - | 22.12 | - |
| 毛利构成(%) | |||||
| 活血止痛膏(%) | 11.88 | 10.07 | 10.32 | 15.15 | 18.17 |
| 基因工程药(%) | 88.12 | 77.90 | 89.68 | 71.78 | 81.83 |
| 其他(%) | - | 12.03 | - | 13.07 | - |